Institutional Investor Research is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Full Article

China Research Providers

Ranking Overview Methodology

Despite having the fastest economic recovery from the pandemic in 2020, China had a rockier 2021 than investors anticipated. 

“Investor sentiment in China has become more pessimistic over the course of 2021,” said Eric Lin, head of research at UBS.

According to Lin, an influx of regulation impacted industries such as property, internet, and after-school tuition. Meanwhile, earnings growth decelerated materially in the third quarter, as the country’s Covid-zero policy — which relies on stringent measures to halt virus transmissions — has continued to affect consumption. 

“Towards the end of the year, investors also had to grapple with the external shock of China ADRs potentially needing to de-list from the U.S., and many wanted to understand the potential sell-off pressures and the impact on liquidity and valuation,” Lin added. 

The result: The MSCI China index underperformed the S&P 500 by close to 50 percent in 2021.

But there are bright spots, according to Peng Wensheng, head of the research department at China International Capital Corp. He noted that some sectors and investment themes are significantly outperforming, such as the electric vehicle supply chain and renewable energy and technology hardware companies. 

Wensheng said that despite the lingering impact of the pandemic, China’s financial markets have maintained steady steps towards opening up and that “competition in sell-side research in China has only intensified under the ongoing entry of global players. At the same time, the pandemic has quickened the digital transformation of the industry and accelerated the integration of digital tools into our daily work.”

Still, the pandemic continues to limit international — and to some extent domestic — travel, so the ability to provide on-the-ground and local insight has become even more paramount, according to UBS’s Lin. “Those sell-side research analysts who are able to offer information advantage will likely draw a bigger audience,” he said.

Click here to continue reading.

To select the members of Institutional Investor’s twelfth annual All-China Research Team, we solicited the opinions of more than 2,800 investment professionals at some 950 institutions. 

This year, participants rated their top firms in each sector and then separately rated individual analysts or economists/strategists at those firms to create two distinct rankings for each sector. A numerical score was produced by weighting each vote by the respondent’s Chinese equity assets under management and the average rating awarded. Using those scores, ranks were determined. Firms/analysts were designated runners‐up when their scores came within 35 percent of the third-place scores.

In order to portray the difference in perspective between domestic and international investors, we divided respondents according to their location to produce two additional rankings: a mainland view and an international view.

The individuals surveyed are kept confidential to ensure continuing cooperation. Voters are subject to eligibility requirements, and winners must achieve a minimum vote count. All ballots are subject to review by our Research Operations Group.

Read more
Subscribe or login to access the results

Unlock essential data and insights

      • Gain a competitive advantage: Hear first about tactical developments
      • Make better decisions: Understand market dynamics in crucial lines of business